Overview
Location
United States, Indiana, York
Total raised
$2.04M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 8, 2026 | Significant Advances in Pharmaceutical Pipelines for Underserved Diseases | Oculis Holding AG has announced that its drug candidate Privosegtor was granted breakthrough therapy designation by the FDA for the treatment of optic neuritis (ON), a rare neuro‑ophthalmic condition. This approval expedites the review of ... |
| Aug 11, 2025 | Two biotech start-ups significantly closer to market | Results of the RAAINBOW Phase 2/3 trial showing efficacy and safety of Legacy Healthcare’s Cinainu in children and adolescents with moderate to severe alopecia areata (AA) have been published in the British Journal of Dermatology. AA is a ... |
| Feb 3, 2023 | LeadiNNg to Scale Up season two kicks off with 12 startups | |
| Jan 17, 2023 | Promising drug for alopecia areata in children and adolescents | |
| Mar 29, 2022 | SERI confirms CHF 58 million SERI-funded EIC Accelerator Grants for 24 start-ups | |
| Jun 17, 2020 | Former Procter & Gamble Vice-Chairman invests in Legacy Healthcare | |
| Jun 17, 2020 | Former Procter & Gamble Vice-Chairman invests in Legacy Healthcare | Legacy Healthcare’s first patented drug substance is an apoptosis-modulation and anti-inflammation agent. From this drug substance, the company has developed a pipeline of innovative drugs in 4 different indications: Alopecia Areata, curren... |
| Sep 17, 2019 | Twelve Swiss startups join Euronext’s Pre-Ipo programme Techshare | |
| Mar 22, 2019 | Former Procter & Gamble Top Executive Invests in Legacy Healthcare |
Show more
Reviews 0
FAQ about Legacy
How much funding has Legacy raised?
Legacy has raised $2.04M in total across 1 funding round.
What has the press written about Legacy?
Parsers VC has collected 12 articles mentioning Legacy, among them “Significant Advances in Pharmaceutical Pipelines for Underserved Diseases” (Jan 8, 2026) and “Two biotech start-ups significantly closer to market” (Aug 11, 2025).
Is Legacy still active?
Yes, Legacy is active; its latest activity on Parsers VC dates from Oct 20, 2026.